Kaj Blennow, professor of clinical neuro chemestry at the Sahlgrenska Academy, has received a major European award for his research on Alzheimers.
The award, which is presented by the French organization IFRAD (Fondation pour la recherche sur Alzheimer), comprises EUR 100,000, most of which EUR 90 000 allocated as a research funding to the University of Gothenburg. The award ceremony took place in connection with a grand gala in Paris on Wednesday, September 25.
“The prize means a lot. Not only for the honor, but also because it entails a major financial allocation that allows us to proceed with our research project in a better way,” Kaj Blennow explains.
You have, of course, received a number of international awards – what is the significance of awards and honors in the world of research?
“That’s hard to say, but I think it plays a significant role in securing international funding, initiating cooperation with other research groups abroad and getting scientific articles published. But I don’t think international prizes have any special significance on the home front.”
Thirteen candidates were nominated for the award, five of whom were Alzheimers researchers from the Swedish Brain Power network. In addition to Kaj Blennow, also nominated were Miia Kivipelto, Lars Lannfelt, Agneta Nordberg and Anders Wimo.
